Chande, Sampada
Caballero, Daniel
Ho, Bryan B.
Fetene, Jonathan
Serna, Juan
Pesta, Dominik
Nasiri, Ali
Jurczak, Michael
Chavkin, Nicholas W.
Hernando, Nati
Giachelli, Cecilia M.
Wagner, Carsten A.
Zeiss, Caroline
Shulman, Gerald I.
Bergwitz, Clemens
Funding for this research was provided by:
NIH/NIDDK (P30DK079310, P30DK079310, P30DK079310, P30DK079310, P30DK079310, P30DK079310, P30DK079310, P30DK079310, P30DK079310, P30DK079310, P30DK079310, P30DK079310, P30DK079310, P30DK079310, P30DK079310)
Article History
Received: 1 December 2019
Accepted: 29 January 2020
First Online: 20 February 2020
Competing interests
: Sampada Chande, Daniel Caballero, Bryan B. Ho, Jonathan Fetene, Juan Serna, Dominik Pesta, Ali Nasiri, Michael Jurczak, Nicholas W. Chavkin, Nati Hernando, Cecilia M. Giachelli and Caroline Zeiss declare that they have no conflict of interest. Carsten A. Wagner has served on advisory boards to Bayer and Medice and received honoraria from Medice. Gerald I. Shulman serves on the advisory boards for Merck, Novo Nordisk, AstraZeneca, Gilead Sciences and Janseen Research and Development and he receives investigator-initiated support from AstraZeneca, Gilead Sciences and Merck. Clemens Bergwitz has received research support from Nutricia North America, Bethesda, MD, USA, for an unrelated project. He serves on the advisory board for Bayer.